Status:

COMPLETED

Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy

Lead Sponsor:

University of Arkansas

Conditions:

Multiple Myeloma

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The purpose of this investigational trial is to find out how well patients respond and how long their response lasts when treated with a standard regimen of dexamethasone with or without thalidomide a...

Detailed Description

Maintenance Dexamethasone Patients will receive 40 mg dexamethasone days 1-4 only, every 3-4 weeks. Response will be assessed at least every 3 months while on maintenance therapy. Appropriate H2 blo...

Eligibility Criteria

Inclusion

  • All patients must have a confirmed diagnosis of previously treated, active multiple myeloma, with hypoproliferative/low risk relapse following at least one autologous transplant.
  • Patients must be 18 years of age or older. Women of childbearing age and fertile men must use a medically acceptable means of birth control while on study and for 6 months thereafter.
  • Patients must sign an informed consent to participate in this study, and be fully aware of the known teratogenic potential of this drug combination.
  • Patients must have a SWOG performance status of 0-2.
  • Patients must have adequate renal function, as defined by serum creatinine \< or = 3.0 mg/dl.
  • Patients must be off chemotherapy (including steroids) and local radiotherapy for \> or equal 3 weeks prior to entering the study.

Exclusion

  • No other concurrent therapy for myeloma is permitted while on protocol.
  • There must be no evidence of active infection requiring IV antibiotics.

Key Trial Info

Start Date :

June 1 1998

Trial Type :

INTERVENTIONAL

End Date :

May 1 2005

Estimated Enrollment :

190 Patients enrolled

Trial Details

Trial ID

NCT00083902

Start Date

June 1 1998

End Date

May 1 2005

Last Update

July 2 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Arkansas for Medical Sciences/MIRT

Little Rock, Arkansas, United States, 72205